Articles with "targeting egfr" as a keyword



Photo from wikipedia

Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment

Sign Up to like & get
recommendations!
Published in 2018 at "International Journal of Cancer"

DOI: 10.1002/ijc.31246

Abstract: Glioblastomas (GBMs) are high‐grade brain tumors, differentially driven by alterations (amplification, deletion or missense mutations) in the epidermal growth factor receptor (EGFR), that carry a poor prognosis of just 12–15 months following standard therapy. A… read more here.

Keywords: response; near infrared; treatment; photoimmunotherapy ... See more keywords
Photo by little_klein from unsplash

Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c01827

Abstract: Drug resistance caused by epidermal growth factor receptor (EGFR) mutation has largely limited the clinical use of EGFR tyrosine kinase inhibitors (EGFR-TKIs) for the treatment of non-small-cell lung cancer (NSCLC). Herein, to overcome the intractable… read more here.

Keywords: protacs targeting; egfr mutants; targeting egfr; covalent ... See more keywords
Photo by tcwillmott from unsplash

Targeting the EGFR pathway shows promise for OA

Sign Up to like & get
recommendations!
Published in 2021 at "Nature Reviews Rheumatology"

DOI: 10.1038/s41584-021-00583-5

Abstract: 0123456789();: while enabling prolonged retention and high cartilage penetration. Similar to EGFR overactivation, intra-articular delivery of these TGFα-conjugated nanoparticles in the knees of mice attenuated the development of surgery-induced OA. “We are currently collaborating with… read more here.

Keywords: egfr pathway; rheumatology; pathway shows; shows promise ... See more keywords
Photo from wikipedia

Allosterically targeting EGFR drug-resistance gatekeeper mutations.

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of thoracic disease"

DOI: 10.21037/jtd.2017.06.43

Abstract: Lung cancer is by far the leading cause of cancer-related death with nearly 1.7 million deaths worldwide in 2016. The most common type of lung cancer is non-small cell lung cancer (NSCLC) accounting for 80%… read more here.

Keywords: lung cancer; allosterically targeting; targeting egfr; cancer ... See more keywords